552 related articles for article (PubMed ID: 28963906)
1. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
Sahai T; Henrichs K; Refaai M; Heal JM; Kirkley SA; Schmidt AE; Mendler JH; Masel D; Liesveld J; Aquina C; Blumberg N
Leuk Res; 2017 Nov; 62():1-3. PubMed ID: 28963906
[TBL] [Abstract][Full Text] [Related]
2. An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients.
Refaai MA; Fialkow LB; Heal JM; Henrichs KF; Spinelli SL; Phipps RP; Masel E; Smith BH; Corsetti JP; Francis CW; Bankey PE; Blumberg N
Vox Sang; 2011 Jul; 101(1):55-60. PubMed ID: 21414009
[TBL] [Abstract][Full Text] [Related]
3. Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidence.
Henrichs KF; Howk N; Masel DS; Thayer M; Refaai MA; Kirkley SA; Heal JM; Blumberg N
Transfusion; 2012 Mar; 52(3):635-40. PubMed ID: 21895675
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
[TBL] [Abstract][Full Text] [Related]
5. ABO and platelet transfusion revisited.
Heal JM; Rowe JM; Blumberg N
Ann Hematol; 1993 Jun; 66(6):309-14. PubMed ID: 8318561
[TBL] [Abstract][Full Text] [Related]
6. The global problem of early deaths in acute promyelocytic leukemia: A strategy to decrease induction mortality in the most curable leukemia.
Jillella AP; Kota VK
Blood Rev; 2018 Mar; 32(2):89-95. PubMed ID: 29033137
[TBL] [Abstract][Full Text] [Related]
7. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
Josephson CD; Castillejo MI; Grima K; Hillyer CD
Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
[TBL] [Abstract][Full Text] [Related]
8. Leukodepleted-ABO-identical blood components in the treatment of hematologic malignancies: a cost analysis.
Blumberg N; Heal JM; Kirkley SA; DiPersio JF; Rapoport AP; Rowe JM
Am J Hematol; 1995 Feb; 48(2):108-15. PubMed ID: 7847323
[TBL] [Abstract][Full Text] [Related]
9. Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia.
Eardley AM; Heller G; Warrell RP
Leukemia; 1994 Jun; 8(6):934-9. PubMed ID: 8207987
[TBL] [Abstract][Full Text] [Related]
10. Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia.
Chamoun K; Kantarjian HM; Wang X; Naqvi K; Aung F; Garcia-Manero G; Borthakur G; Jabbour E; Kadia T; Daver N; DiNardo CD; Jain N; Konopleva M; Cortes J; Ravandi F; Yilmaz M
Cancer; 2019 Sep; 125(18):3219-3224. PubMed ID: 31150121
[TBL] [Abstract][Full Text] [Related]
11. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
[TBL] [Abstract][Full Text] [Related]
12. Emergency use of prethawed Group A plasma in trauma patients.
Zielinski MD; Johnson PM; Jenkins D; Goussous N; Stubbs JR
J Trauma Acute Care Surg; 2013 Jan; 74(1):69-74; discussion 74-5. PubMed ID: 23271079
[TBL] [Abstract][Full Text] [Related]
13. Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs.
Julmy F; Ammann RA; Taleghani BM; Fontana S; Hirt A; Leibundgut K
Transfusion; 2009 Jan; 49(1):21-33. PubMed ID: 18774963
[TBL] [Abstract][Full Text] [Related]
14. What would Karl Landsteiner do? The ABO blood group and stem cell transplantation.
Heal JM; Liesveld JL; Phillips GL; Blumberg N
Bone Marrow Transplant; 2005 Nov; 36(9):747-55. PubMed ID: 16044140
[TBL] [Abstract][Full Text] [Related]
15. Transfusion of ABO non-identical platelets does not influence the clinical outcome of patients undergoing autologous haematopoietic stem cell transplantation.
Solves P; Carpio N; Balaguer A; Romero S; Iacoboni G; Gómez I; Lorenzo I; Moscardó F; Sanz J; Lopez F; Martin G; Jarque I; Montesinos P; De La Rubia J; Sanz G; Sanz MA
Blood Transfus; 2015 Jul; 13(3):411-6. PubMed ID: 25761311
[TBL] [Abstract][Full Text] [Related]
16. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
17. Effects of ABO Matching of Platelet Transfusions in Critically Ill Children.
Nellis ME; Goel R; Karam O; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC; ;
Pediatr Crit Care Med; 2019 Feb; 20(2):e61-e69. PubMed ID: 30422914
[TBL] [Abstract][Full Text] [Related]
18. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
[TBL] [Abstract][Full Text] [Related]
19. ABO incompatible platelets: risks versus benefit.
Dunbar NM; Ornstein DL; Dumont LJ
Curr Opin Hematol; 2012 Nov; 19(6):475-9. PubMed ID: 22914587
[TBL] [Abstract][Full Text] [Related]
20. Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery.
Blumberg N; Heal JM; Hicks GL; Risher WH
Transfusion; 2001 Jun; 41(6):790-3. PubMed ID: 11399821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
